Metagenomi (MGX) Earnings Date, Estimates & Call Transcripts $1.82 -0.01 (-0.27%) As of 02:51 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Metagenomi Earnings Summary Metagenomi posted Q2 2025 earnings on August 12, 2025, reporting an EPS of -$0.54, which beat the consensus estimate of -$0.68 by $0.14. Quarterly revenue was reported to be $8.51 million, above the consensus estimate of $7.72 million. With a trailing EPS of -$2.36, Metagenomi's earnings are expected to decrease next year, from ($2.46) to ($2.52) per share. Latest Q2 Earnings DateAug. 12EstimatedConsensus EPS (Aug. 12) -$0.68 Actual EPS (Aug. 12) -$0.54 Beat By $0.14 Actual Revenue (Aug. 12) $8.51MQ2 2025 Earnings ResourcesQ2 2025 Earnings Report Quarterly Report (10-Q) Press Release (8-K)Powered by Get Metagenomi Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Metagenomi and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataMGX Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.MGX Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Metagenomi Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20251-$0.47-$0.47-$0.47Q2 20251-$0.54-$0.54-$0.54Q3 20251-$0.57-$0.57-$0.57Q4 20251-$0.62-$0.62-$0.62 FY 2025 4 -$2.20 -$2.20 -$2.20 Q1 20261-$0.66-$0.66-$0.66Q2 20261-$0.71-$0.71-$0.71Q3 20261-$0.75-$0.75-$0.75Q4 20261-$0.79-$0.79-$0.79 Metagenomi Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails8/12/2025Q2 2025-$0.68-$0.54+$0.14-$0.54$7.72M$8.51M5/13/2025Q1 2025-$0.62-$0.68 -$0.06-$0.68$8.75M$4.13M3/17/2025Q4 2024-$0.62-$0.63 -$0.01-$0.63$13.18M$9.61M8/14/2024Q2 2024-$0.59-$0.29+$0.30-$0.29$14.80M$20.01M5/14/2024Q1 2024-$0.95-$1.19 -$0.24-$1.19$8.30M$11.16M Metagenomi Earnings - Frequently Asked Questions When did Metagenomi announce their last quarterly earnings? Metagenomi (NASDAQ:MGX) last announced its quarterly earning data on Tuesday, August 12, 2025. Learn more on MGX's earnings history. Did Metagenomi beat their earnings estimates last quarter? In the previous quarter, Metagenomi (NASDAQ:MGX) reported ($0.54) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.68) by $0.14. Learn more on analysts' earnings estimate vs. MGX's actual earnings. How much revenue does Metagenomi generate each year? Metagenomi (NASDAQ:MGX) has a recorded annual revenue of $33.77 million. How much profit does Metagenomi generate each year? Metagenomi (NASDAQ:MGX) has a recorded net income of -$78.06 million. MGX has generated -$2.36 earnings per share over the last four quarters. What is Metagenomi's EPS forecast for next year? Metagenomi's earnings are expected to decrease from ($2.46) per share to ($2.52) per share in the next year. More Earnings Resources from MarketBeat Related Companies MRNA Earnings Date ALT Earnings Date IMAB Earnings Date RNAC Earnings Date DRUG Earnings Date LFCR Earnings Date GLUE Earnings Date DBVT Earnings Date AVIR Earnings Date SGMT Earnings Date Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles DLocal Stock Soars 43% After Earnings Beat and Raised GuidanceGreen Dot's 30% Rally: Turnaround Takes Off on Explosive EarningsElbit Systems Jumps on Record Earnings and a $1.6B ContractBrinker Serves Up Earnings Beat, Sidesteps Cost PressuresWhy BigBear.ai Stock's Dip on Earnings Can Be an Opportunity CrowdStrike Faces Valuation Test Before Key Earnings ReportPost-Earnings, How Does D-Wave Stack Up Against Quantum Rivals? This page (NASDAQ:MGX) was last updated on 8/20/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredWashington Thinks They Own Your Bank AccountWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredNew law could create $3.7 trillion tsunami.During a meeting in Washington D.C., Jeff Brown discovered a bold initiative. He calls it “President Trump’...Brownstone Research | SponsoredHow high will gold surge?Weiss Gold Veteran Makes Shocking New Call Weiss expert Sean Brodrick went out on a limb last year and decl...Weiss Ratings | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredTurn $1K into $50K with This DeFi GemBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredGenerate up to $5,000/month with 10X less money?The secret to retiring without a million-dollar nest egg. I'm talking about generating enough monthly inco...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Metagenomi, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Metagenomi With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access